NOTES

By definition cervical carcinoma ‘in situ’ has not spread. Therefore it is not considered to be a potential risk to any recipient of donated material. Women who have completed successful therapy for carcinoma in situ of the cervix may be accepted if no further treatment is planned, even if regular review of smears is being undertaken. Women who have had an abnormal smear, can be accepted even if regular review of smears is undertaken, if no treatment is required. Investigations may include colposcopy, a cervical cone biopsy and/or a LLETZ procedure. Colposcopy is a rigid scope so the 4 month deferral does not apply

ACCEPT: (if the donor has cervical dysplasia / cervical carcinoma in situ)

• If the donor has regular smears but no treatment is required

• If treatment is complete and the donor has been discharged to routine screening. It is not necessary to wait for a normal smear result before donating
• If the donor has completed successful therapy for carcinoma in situ of the cervix and no further treatment is planned, even if regular review of smears is being undertaken

DEFER:

• If the donor is undergoing investigation or treatment
• If colposcopy is performed as part of the investigation of cervical dysplasia and an abnormality is noted and the donor undergoes a cervical cone biopsy or a LETTS procedure: DEFER until she has completed successful treatment

PERMANENTLY EXCLUDE:

• If the donor is diagnosed with invasive cervical cell carcinoma

SEE IF RELEVANT

• HUMAN PAPILLOMA VIRUS (HPV)
• DEFERRAL TIMES FOR VACCINE ADMINISTRATION (VACCINATION)

• CERVICAL CONE BIOPSY